A company still losing money with growing sales. Institutions are trimming.
Facts from SEC filings, not a recommendation.
Last 12 months: $2.4M, down 1.3% from the 12 months before. Over 5 years, sales grew about 2.0% a year.
Price chart by TradingView.
From annual reports filed with the SEC. Gross margin doesn't apply to banks and insurers, so it isn't scored. Not in this company's SEC data, so not scored: free cash flow positive, share count not growing. A checklist is a starting point for research, not a verdict.
No open-market insider buys or sells in the last 90 days.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
Institutions cut 24.4% from their holdings. 7 bought, 12 sold.
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
100,000 shares
100,000 shares
100,000 shares
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page